Compared with the baseline, the OSDI score declined to 29.86 ± 6.24 after the BoNT-A+APP treatment, showing the effective improvement of the combined management in alleviating dry eye symptoms (p = 0.000, Figure 4A). Here, APP is linked to dry eye syndrome.